All day - TechCrunch Disrupt will take place in San Francisco. Notable speakers include Rivian ( RIVN) CEO RJ Scaringe, ...

The risk is in the other 493, which have been re-valued to Mag 7 P/Es without earning Mag 7 profits. It's hardly an ...

Investors continue to raise their private markets allocations, and the evidence suggests good reasons for doing so. Read more ...

EQT Corporation trades at a 20% EBITDA premium to peers and is fairly valued for a $3.60 long-term gas price. Read more on ...

Entrada Therapeutics is rated Buy with a $8.50 fair value, offering ~52% upside from $5.61, driven by potential validation of ...

Alphamin Resources has shifted focus to exploration around its Bisie resource, presenting speculative growth potential. Read ...

B cost cuts by 2027–28, dividend uncertainty after 50% cut, and limited growth targets. Read here for more details.

Global goods trade further picked up momentum at the end of Q3, with new export orders rising worldwide at the fastest pace ...

In the Treasury market, the tripwire most often invoked is the yield beyond which lie monsters. Read more here.

JPMorgan, Bank of America, Citigroup and Wells Fargo are all expected to post higher revenue year-on-year in Q3. Read more ...

Eric Fine discusses the current economic landscape, focusing on the implications of stagflation, geopolitical risks, and ...

While market jitters have kept some IPO candidates on the sidelines, biotechs continue to tap the public market, with two ...